167 related articles for article (PubMed ID: 28989040)
1. Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience.
Tokaca N; Barth S; O'Brien M; Bhosle J; Fotiadis N; Wotherspoon A; Thompson L; Popat S
J Thorac Oncol; 2018 Jan; 13(1):63-72. PubMed ID: 28989040
[TBL] [Abstract][Full Text] [Related]
2. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.
Folch E; Yamaguchi N; VanderLaan PA; Kocher ON; Boucher DH; Goldstein MA; Huberman MS; Kent MS; Gangadharan SP; Costa DB; Majid A
J Thorac Oncol; 2013 Nov; 8(11):1438-1444. PubMed ID: 24128714
[TBL] [Abstract][Full Text] [Related]
3. Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer.
Vanderlaan PA; Yamaguchi N; Folch E; Boucher DH; Kent MS; Gangadharan SP; Majid A; Goldstein MA; Huberman MS; Kocher ON; Costa DB
Lung Cancer; 2014 Apr; 84(1):39-44. PubMed ID: 24513263
[TBL] [Abstract][Full Text] [Related]
4. Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer.
Fintelmann FJ; Troschel FM; Kuklinski MW; McDermott S; Petranovic M; Digumarthy SR; Sharma A; Troschel AS; Price MC; Hariri LP; Gilman MD; Shepard JO; Sequist LV; Piotrowska Z
Oncologist; 2019 Dec; 24(12):1570-1576. PubMed ID: 31152082
[TBL] [Abstract][Full Text] [Related]
5. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
[TBL] [Abstract][Full Text] [Related]
6. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
[TBL] [Abstract][Full Text] [Related]
8. Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
Gill RR; Murphy DJ; Kravets S; Sholl LM; Janne PA; Johnson BE
J Surg Oncol; 2018 Dec; 118(7):1170-1177. PubMed ID: 30261097
[TBL] [Abstract][Full Text] [Related]
9. KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
Yokota K; Sasaki H; Okuda K; Shimizu S; Shitara M; Hikosaka Y; Moriyama S; Yano M; Fujii Y
Oncol Rep; 2012 Oct; 28(4):1187-92. PubMed ID: 22797671
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.
Tam AL; Kim ES; Lee JJ; Ensor JE; Hicks ME; Tang X; Blumenschein GR; Alden CM; Erasmus JJ; Tsao A; Lippman SM; Hong WK; Wistuba II; Gupta S
J Thorac Oncol; 2013 Apr; 8(4):436-42. PubMed ID: 23442309
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
Sánchez-Font A; Chalela R; Martín-Ontiyuelo C; Albero-González R; Dalmases A; Longarón R; Alonso-Espinaco V; Curull V; Bellosillo B; Pijuan L
Cancer Cytopathol; 2018 Oct; 126(10):860-871. PubMed ID: 30291816
[TBL] [Abstract][Full Text] [Related]
12. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
[TBL] [Abstract][Full Text] [Related]
14. Real-world data of EGFR mutation testing in Chinese non-small cell carcinoma: Low tumor cell number and tumor cellularity can be accepted.
Gu Y; Li Y; Zhao S; Jin M; Lu J; Jiang X
Pathol Res Pract; 2022 Aug; 236():153965. PubMed ID: 35700580
[TBL] [Abstract][Full Text] [Related]
15. Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.
Lee K; Um SW; Jeong BH; Yang JW; Choi YL; Han J; Kim H; Kwon OJ
Intern Med; 2016; 55(21):3105-3111. PubMed ID: 27803402
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing.
Toffart AC; Asfari S; Mc Leer A; Reymond E; Jankowski A; Moro-Sibilot D; Stephanov O; Ghelfi J; Lantuejoul S; Ferretti GR
Lung Cancer; 2020 Feb; 140():93-98. PubMed ID: 31901769
[TBL] [Abstract][Full Text] [Related]
17. Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer.
Haentschel M; Boeckeler M; Ehab A; Wagner R; Spengler W; Steger V; Boesmueller H; Horger M; Lewis RA; Fend F; Kanz L; Bonzheim I; Hetzel J
Lung Cancer; 2020 Mar; 141():56-63. PubMed ID: 31955001
[TBL] [Abstract][Full Text] [Related]
18. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
[No Abstract] [Full Text] [Related]
19. Adequacy of samples obtained via percutaneous core-needle rebiopsy for EGFR T790M molecular analysis in patients with non-small cell lung cancer following acquired resistance to first-line therapy: A systematic review and meta-analysis.
Poudel B; Desman J; Aihara G; Weidman DI; Tsang A; Kovrizhkin K; Pereira T; Arun S; Pradeep T; Matin S; Liddell RP
Cancer Treat Res Commun; 2021; 29():100470. PubMed ID: 34628209
[TBL] [Abstract][Full Text] [Related]
20. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
